{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T22:33:12Z","timestamp":1786660392272,"version":"build-2736575974"},"reference-count":18,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"3","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,6]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n<jats:p><jats:italic>Strongyloides stercoralis<\/jats:italic> is a parasitic roundworm that is present worldwide and can cause lifelong, often asymptomatic, infection. Immunosuppression, particularly by corticosteroids, is a risk factor for hyperinfection syndrome and disseminated strongyloidiasis\u2014severe disease states that can lead to septic shock and death. Our institution implemented a strongyloidiasis screening and empiric ivermectin treatment protocol for inpatients receiving high-dose corticosteroids for severe COVID-19. Among 487 COVID-19 admissions treated with high-dose corticosteroids from June 10, 2020 to March 31, 2021, 61% of those with demographics at risk for <jats:italic>Strongyloides<\/jats:italic> exposure were screened for <jats:italic>Strongyloides<\/jats:italic> and treated empirically with ivermectin. Adherence to the protocol declined over time during the study period. The empiric ivermectin protocol appeared safe, but more research is needed to determine the effect on hyperinfection and\/or disseminated strongyloidiasis risk and mortality rate, as well as to improve institutional adherence to the protocol.<\/jats:p>","DOI":"10.4269\/ajtmh.23-0121","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T13:39:29Z","timestamp":1694007569000},"page":"650-655","source":"Crossref","is-referenced-by-count":2,"title":["Implementation and Outcomes of an Empiric Ivermectin Strongyloides Treatment Protocol for Patients Receiving High-Dose Corticosteroids for Severe COVID-19"],"prefix":"10.4269","volume":"109","author":[{"given":"Benjamin","family":"Swart","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hennepin Healthcare, Minneapolis, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"Ahiskali","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hennepin Healthcare, Minneapolis, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack M.","family":"Wolf","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Shaughnessy","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Hennepin Healthcare, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","series-title":"Infect Dis Clin North Am","first-page":"135","article-title":"Strongyloidiasis: a neglected tropical disease","volume":"33","author":"Krolewiecki","year":"2019"},{"key":"b2","series-title":"PLoS Negl Trop Dis","first-page":"e2288","article-title":"Strongyloides stercoralis: global distribution and risk factors","volume":"7","author":"Sch\u00e4r","year":"2013"},{"key":"b3","series-title":"Lancet Infect Dis","first-page":"1181","article-title":"Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (strong treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial","volume":"19","author":"Buonfrate","year":"2019"},{"key":"b4","series-title":"J Infect Chemother","first-page":"94","article-title":"Efficacy of ivermectin for chronic strongyloidiasis: two single doses given 2 weeks apart","volume":"8","author":"Zaha","year":"2002"},{"key":"b5","series-title":"Clin Transplant","first-page":"e13618","article-title":"Intestinal parasites including cryptosporidium, Cyclospora, Giardia, and microsporidia, Entamoeba histolytica, Strongyloides, schistosomiasis, and Echinococcus: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"La Hoz","year":"2019"},{"key":"b6","series-title":"J Parasit Dis","first-page":"167","article-title":"Strongyloides stercoralis hyperinfection syndrome: a deeper understanding of a neglected disease","volume":"43","author":"Vasquez-Rios","year":"2019"},{"key":"b7","series-title":"Emerg Infect Dis","first-page":"401","article-title":"Clinical characteristics of disseminated strongyloidiasis, Japan, 1975\u20132017","volume":"26","author":"Mukaigawara","year":"2020"},{"key":"b8","series-title":"ACG Case Rep J","first-page":"1","article-title":"Strongyloides stercoralis hyperinfection syndrome as a cause of fatal gastrointestinal hemorrhage","volume":"6","author":"Rao","year":"2019"},{"key":"b9","series-title":"PLoS Negl Trop Dis","first-page":"e0006229","article-title":"Accuracy of molecular biology techniques for the diagnosis of Strongyloides stercoralis infection: a systematic review and meta-analysis","volume":"12","author":"Buonfrate","year":"2018"},{"key":"b10","series-title":"N Engl J Med","first-page":"693","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","year":"2021"},{"key":"b11","series-title":"Science","first-page":"eabg5298","article-title":"Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile","volume":"372","author":"Mena","year":"2021"},{"key":"b12","series-title":"Am J Trop Med Hyg","first-page":"1590","article-title":"Case report: disseminated strongyloidiasis in a patient with COVID-19","volume":"103","author":"Lier","year":"2020"},{"key":"b13","series-title":"Infection.","first-page":"539","article-title":"Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia","volume":"49","author":"Marchese","year":"2021"},{"key":"b14","series-title":"Diagnostics (Basel)","first-page":"1645","article-title":"Ivermectin for prophylaxis and treatment of COVID-19: a systematic review and meta-analysis","volume":"11","author":"Cruciani","year":"2021"},{"key":"b15","series-title":"Cochrane Database Syst Rev","first-page":"CD015017","article-title":"Ivermectin for preventing and treating COVID-19","volume":"7","author":"Popp","year":"2021"},{"key":"b16","series-title":"Filaria J","first-page":"S7","article-title":"Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future","volume":"2","author":"Twum-Danso","year":"2003"},{"key":"b17","series-title":"JAMA Intern Med","first-page":"1345","article-title":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy","volume":"180","author":"Grasselli","year":"2020"},{"key":"b18","year":"2022"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/109\/3\/article-p650.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/109\/3\/article-p650.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/109\/3\/article-p650.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T13:39:29Z","timestamp":1694007569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/109\/3\/article-p650.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":18,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.23-0121","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,6]]}}}